» Articles » PMID: 21084396

Leiomyoma Simultaneously Impair Endometrial BMP-2-mediated Decidualization and Anticoagulant Expression Through Secretion of TGF-β3

Overview
Specialty Endocrinology
Date 2010 Nov 19
PMID 21084396
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Uterine leiomyomas occur in 30-70% of reproductive-age women. Leiomyoma reduce implantation, increase miscarriage risk, and increase menstrual bleeding. We hypothesized that endometrial defects induced by leiomyoma result in menorrhagia and reproductive dysfunction.

Objectives: We evaluated the effect of leiomyoma on endometrial gene expression essential for implantation and hemostasis both in vivo and in primary endometrial stromal cells (ESC).

Design And Setting: We conducted a case control and in vitro study at a university medical center.

Patients: The study included 24 subjects with or without leiomyoma. INTERVENTION/MAIN OUTCOME MEASURED: Endometrium, myometrium, leiomyoma, and ESC were obtained. Immunohistochemistry was used to evaluate TGF-β3, bone morphogenetic protein (BMP) receptors (BMPRs), plasminogen activator inhibitor 1 (PAI-1), and thrombomodulin in vivo. BMP-2 secretion was assessed by ELISA. ESC were treated with recombinant human (rh) BMP-2 or rhTGF-β3. Expression of HOXA10, LIF, BMPRs, antithrombin III (ATIII), thrombomodulin, and PAI-1 was assessed by quantitative RT-PCR.

Results: ESC from controls secreted more BMP-2 than those from women with leiomyoma. HOXA10 and LIF expression increased after rhBMP-2 treatment of normal but not leiomyoma-associated ESC. In vivo leiomyoma-associated endometrium expressed lower levels of BMPR 1A, 1B, and 2 than controls. Leiomyoma expressed high levels of TGF-β3; TGF-β3 treatment of ESC reduced expression of BMPRs. Similarly, leiomyoma-associated endometrium expressed less PAI-1 and thrombomodulin in vivo. In ESC, TGF-β3 reduced expression of PAI-1, ATIII, and thrombomodulin.

Conclusions: Leiomyoma-secreted TGF-β3 induces BMP-2 resistance in endometrium by down-regulation of BMPR-2, likely causing defective endometrial decidualization. TGF-β3 also reduces expression of PAI-1, ATIII, and thrombomodulin in endometrium, likely contributing to menorrhagia. A single molecular signal targeting endometrium may mediate both leiomyoma-induced infertility and bleeding.

Citing Articles

Evaluating the Effect of Epigallocatechin Gallate (EGCG) in Reducing Folate Levels in Reproductive Aged Women by MTHFR and DHFR Genotype in Combination With Letrozole or Clomiphene.

Johnson J, Siblini H, Al-Hendy A, Segars J, Gonzalez F, Taylor H Clin Transl Sci. 2025; 18(3):e70189.

PMID: 40077973 PMC: 11903501. DOI: 10.1111/cts.70189.


Integral Roles of the TGFβ Signaling Pathway in Uterine Function and Disease.

Unser A, Monsivais D Endocrinology. 2025; 166(3).

PMID: 39950970 PMC: 11843549. DOI: 10.1210/endocr/bqaf032.


Mechanism of Endometrial Receptivity Affected by Fibroids.

Sun P, Zhang C, Wang W, Ma H Am J Reprod Immunol. 2024; 92(6):e70022.

PMID: 39625040 PMC: 11613313. DOI: 10.1111/aji.70022.


Navigating Pregnancy With Uterine Fibroids: A Case Study.

Patel D, Chaudhari K, Acharya N, Shrivastava D, Dave A, Patel A Cureus. 2024; 16(7):e64793.

PMID: 39156440 PMC: 11330289. DOI: 10.7759/cureus.64793.


Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) - protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine....

Al-Hendy A, Segars J, Taylor H, Gonzalez F, Siblini H, Zamah M BMJ Open. 2024; 14(1):e078989.

PMID: 38216200 PMC: 10806662. DOI: 10.1136/bmjopen-2023-078989.


References
1.
Zhang H, Bradley A . Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development. 1996; 122(10):2977-86. DOI: 10.1242/dev.122.10.2977. View

2.
Cubellis M, Wun T, Blasi F . Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J. 1990; 9(4):1079-85. PMC: 551782. DOI: 10.1002/j.1460-2075.1990.tb08213.x. View

3.
Massague J . The transforming growth factor-beta family. Annu Rev Cell Biol. 1990; 6:597-641. DOI: 10.1146/annurev.cb.06.110190.003121. View

4.
van Zonneveld A, Curriden S, Loskutoff D . Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proc Natl Acad Sci U S A. 1988; 85(15):5525-9. PMC: 281790. DOI: 10.1073/pnas.85.15.5525. View

5.
Casslen B, ASTEDT B . Occurrence of both urokinase and tissue plasminogen activator in the human endometrium. Contraception. 1983; 28(6):553-64. DOI: 10.1016/0010-7824(83)90106-3. View